Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
10.23
-1.18 (-10.34%)
At close: Mar 13, 2026, 4:00 PM EDT
10.27
+0.04 (0.34%)
After-hours: Mar 13, 2026, 7:30 PM EDT
Moolec Science Revenue
Moolec Science had revenue of $2.64M in the quarter ending December 31, 2024, with 948.32% growth. This brings the company's revenue in the last twelve months to $7.83M, up 170.36% year-over-year. In the fiscal year ending June 30, 2024, Moolec Science had annual revenue of $5.63M with 521.53% growth.
Revenue (ttm)
$7.83M
Revenue Growth
+170.36%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 5.63M | 4.72M | 521.53% |
| Jun 30, 2023 | 905.05K | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 7.70M |
| Evogene | 3.85M |
| CollPlant Biotechnologies | 2.48M |
| SciSparc | 1.31M |
| Kiora Pharmaceuticals | 20.00K |
| Alaunos Therapeutics | 6.00K |
| Pulmatrix | 3.00K |
MLEC News
- 4 weeks ago - Moolec Science (MLEC) Stock Explodes 90% After GLA Update - Benzinga
- 4 weeks ago - Moolec Science Achieves One of the Highest Commercial-Scale GLA Concentrations From U.S. GLASO1 Crushing - Accesswire
- 6 weeks ago - Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions - Accesswire
- 7 weeks ago - Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement - Accesswire
- 7 weeks ago - Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement - Accesswire
- 2 months ago - Moolec Science Announces Effectiveness of Share Consolidation - Accesswire
- 2 months ago - Moolec Receives Staff Determination Letter and Provides Update on Nasdaq Listing Compliance Status - Accesswire
- 2 months ago - Moolec Science SA Announces the Implementation of a Share Consolidation of Its Ordinary Shares, Par Value U.S.$0.10 Per Share (the "Shares") - Accesswire